These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36453279)

  • 1. PPARγ (Peroxisome Proliferator-Activated Receptor γ) Deacetylation Suppresses Aging-Associated Atherosclerosis and Hypercholesterolemia.
    Zahr T; Liu L; Chan M; Zhou Q; Cai B; He Y; Aaron N; Accili D; Sun L; Qiang L
    Arterioscler Thromb Vasc Biol; 2023 Jan; 43(1):30-44. PubMed ID: 36453279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARγ Deacetylation Confers the Antiatherogenic Effect and Improves Endothelial Function in Diabetes Treatment.
    Liu L; Fan L; Chan M; Kraakman MJ; Yang J; Fan Y; Aaron N; Wan Q; Carrillo-Sepulveda MA; Tall AR; Tabas I; Accili D; Qiang L
    Diabetes; 2020 Aug; 69(8):1793-1803. PubMed ID: 32409492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
    Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1647-53. PubMed ID: 15947238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E receptor-2 deficiency enhances macrophage susceptibility to lipid accumulation and cell death to augment atherosclerotic plaque progression and necrosis.
    Waltmann MD; Basford JE; Konaniah ES; Weintraub NL; Hui DY
    Biochim Biophys Acta; 2014 Sep; 1842(9):1395-405. PubMed ID: 24840660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-Restricted Feeding Reduces Atherosclerosis in LDLR KO Mice but Not in ApoE Knockout Mice.
    Chaix A; Lin T; Ramms B; Cutler RG; Le T; Lopez C; Miu P; Pinto AFM; Saghatelian A; Playford MP; Mehta NN; Mattson MP; Gordts P; Witztum JL; Panda S
    Arterioscler Thromb Vasc Biol; 2024 Sep; 44(9):2069-2087. PubMed ID: 39087348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of endothelial peroxisome proliferator-activated receptor γ accelerates diet-induced atherogenesis in LDL receptor-null mice.
    Qu A; Shah YM; Manna SK; Gonzalez FJ
    Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):65-73. PubMed ID: 22015658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.
    Bai L; Li Z; Li Q; Guan H; Zhao S; Liu R; Wang R; Zhang J; Jia Y; Fan J; Wang N; Reddy JK; Shyy JY; Liu E
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1470-1481. PubMed ID: 28642237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-γ-regulated genes.
    Babaev VR; Runner RP; Fan D; Ding L; Zhang Y; Tao H; Erbay E; Görgün CZ; Fazio S; Hotamisligil GS; Linton MF
    Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1283-90. PubMed ID: 21474828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Tyrosine Phosphatase SHP2 in Macrophages Acts as an Antiatherosclerotic Regulator in Mice.
    Wu C; Zheng P; Ma L; Xu C; Hu L; Yang Z; Fei F; Shen Z; Zhang X; Wu Z; Cheng H; Mao W; Ke Y
    Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):202-217. PubMed ID: 37942607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
    Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
    Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr(-/-) mice.
    Silva JC; César FA; de Oliveira EM; Turato WM; Tripodi GL; Castilho G; Machado-Lima A; de Las Heras B; Boscá L; Rabello MM; Hernandes MZ; Pitta MG; Pitta IR; Passarelli M; Rudnicki M; Abdalla DS
    Pharmacol Res; 2016 Feb; 104():49-60. PubMed ID: 26706782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
    Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of circadian gene cryptochromes in bone marrow-derived cells protects against atherosclerosis in LDLR
    Lin YS; Tsai ML; Hsieh IC; Wen MS; Wang CY
    FASEB J; 2021 Feb; 35(2):e21309. PubMed ID: 33423309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
    Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
    Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression.
    Duan Y; Chen Y; Hu W; Li X; Yang X; Zhou X; Yin Z; Kong D; Yao Z; Hajjar DP; Liu L; Liu Q; Han J
    J Biol Chem; 2012 Jul; 287(28):23667-77. PubMed ID: 22593575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice.
    Gurzeler E; Ruotsalainen AK; Laine A; Valkama T; Kettunen S; Laakso M; Ylä-Herttuala S
    PLoS One; 2021; 16(11):e0258408. PubMed ID: 34767557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lectin-like oxidized low-density lipoprotein receptor-1 promotes endothelial dysfunction in LDL receptor knockout background.
    Hofmann A; Brunssen C; Poitz DM; Langbein H; Strasser RH; Henle T; Ravens U; Morawietz H
    Atheroscler Suppl; 2017 Nov; 30():294-302. PubMed ID: 29096854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte Overexpression of Intracellular NAMPT Attenuates Atherosclerosis by Regulating PPARγ-Dependent Monocyte Differentiation and Function.
    Bermudez B; Dahl TB; Medina I; Groeneweg M; Holm S; Montserrat-de la Paz S; Rousch M; Otten J; Herias V; Varela LM; Ranheim T; Yndestad A; Ortega-Gomez A; Abia R; Nagy L; Aukrust P; Muriana FJG; Halvorsen B; Biessen EAL
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1157-1167. PubMed ID: 28408371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.